-
Catalyst Pharmaceuticals' (CPRX) "Overweight" Rating Reaffirmed at Stephens
Source: Buzz FX / 28 Feb 2025 10:06:15 America/New_York
Catalyst Pharmaceuticals' (CPRX) "Overweight" Rating Reaffirmed at Stephens Written by MarketBeat February 28, 2025 Share Link copied to clipboard. Catalyst Pharmaceuticals ( NASDAQ:CPRX - Get Free Report ) 's stock had its "overweight" rat
Read more...